Emphysema

• FDA approval · 2024-09-05
  FDA Approved: THEOPHYLLINE — Original Application (Strides Pharma Science Limited)

  FDA approves a generic Theophylline from Strides Pharma Science Limited via an Original Application (ANDA).

• FDA approval · 2023-03-20
  FDA Approved: THEOPHYLLINE — Original Application (Amneal Pharmaceuticals NY LLC)

  FDA approved Amneal's Theophylline (generic) under an Original Application (ANDA 216276). Theophylline is indicated for relief of bronchospa…

• FDA approval · 2016-06-09
  FDA Approved: COMBIVENT RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Combivent Respimat (ipratropium bromide and albuterol) from Boehringer Ingelheim Pharmaceuticals…

• FDA approval · 2011-10-07
  FDA Approved: COMBIVENT RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

  FDA approved Combivent Respimat (ipratropium bromide and albuterol) in an original application for relief of bronchospasm associated with ch…

• FDA approval · 2010-07-13
  FDA Approved: THEOPHYLLINE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's Theophylline from an Original Application; Theophylline is a bronchodilator used to treat symptoms of obstructive ai…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.